Association Institut De Myologie — Clinical Trial Site

13 Registered trials

7 Currently recruiting

Organisation

Association Institut De Myologie

Location

Paris, France

Identifier

ORG-100046467

Address

Porte 20 2eme Etage, 26 Avenue Du Docteur Arnold Netter, 75012, France

Departments

I-Motion institute
I-Motion, Hopital Armand Trousseau
Institut de Myologie
Internal Medicine
Neurologie
Neurology
Neuromyology
Paediatric
Plateforme d’essais cliniques I-Motion Adultes
Plateforme des essais cliniques adultes I-MOTION Adultes
Research center for pediatric neuromuscular diseases
Service of Neuromyology

Clinical trials at this site (13)

Search interface

ATA-200 gene therapy trial in patients with LGMDR5 Pending

2023-506440-16-00 limb-girdle muscular dystrophy type R5 (previously name 7
Randomised, double-blind, placebo-controlled, multicentre study to evaluate the efficacy, safety and tolerability of givinostat in non-ambul… Recruiting

2023-503521-19-00 Duchenne muscular dystrophy (DMD) 5 2024-02-09
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy Recruiting

2024-520130-29-00 Spinal Muscular Atrophy 4 2025-12-17
A Study of the Long-Term Safety and Efficacy of VX-670 in Patients With Myotonic Dystrophy Type I Recruiting

2024-517983-47-00 Myotonic Dystrophy 9 2025-11-25
An Open-Label, Randomized, Cross-Over Study to Investigate the Efficacy and Safety of Mexiletine PR compared to Mexiletine IR in Patients wi… Recruiting

2024-514970-27-00 Non-Dystrophic Myotonias (NDM) 5 2025-09-03
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE) Recruiting

2024-517529-26-00 Chronic Inflammatory Demyelinating Polyneuropathy 5 2025-08-04
A Phase 1/2 Study of VX-670 in Adult Subjects with Myotonic Dystrophy Type 1 Recruiting

2023-506028-10-00 Myotonic Dystrophy 7 2024-12-11
A clinical study in 3 parts with a microdystrophin (called GNT0004), a new gene therapy in boys with Duchenne disease who can still walk. Th… Recruiting

2023-505187-11-00 Duchenne Muscular Dystrophy 7 2021-03-01
A research study to compare different doses of a new investigational medicinal product for treatment of certain patients with Duchenne muscu… Ended

2024-511492-15-00 Duchenne Muscular Dystrophy 5 2021-12-09
N/A Ended

2024-513086-39-00 Spinal Muscular Atrophy 5 2020-06-16
Safety and Efficacy of NMD670 in Adult Patients with Type 1 and Type 2 Charcot-Marie-Tooth Disease Ended

2023-507892-23-00 Charcot-Marie-Tooth Disease Type 1 and Type 2 4 2024-08-30
A Phase 2 proof of concept study to evaluate the efficacy and safety of daxdilimab in participants with dermatomyositis or anti-synthetase i… Ended

2022-502810-10-00 Dermatomyositis (DM) or anti-synthetase inflammatory my 4 2023-09-12
WALKALS : A pilot phase II study to evaluate the effect of salbutamol on walking capacity in ambulatory ALS patients. Expired

2022-501624-14-00 Amyotrophic Lateral Sclerosis (ALS) 4